Myocardial ischemia/reperfusion injury (MI/RI) remains a major therapeutic challenge in acute myocardial infarction due to ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

Annual Meeting, GE HealthCare will showcase a wave of significant innovations grounded by its legacy and deep, global commitment to advancing precision care. For more than a ...

Chronic stable angina pectoris is the most prevalent symptomatic manifestation of ischaemic heart disease, and its management is a priority (Box 1). Current clinical guidelines recommend antianginal ...

New study shows a longer course of dual antithrombotic therapy may not be necessary for some patients with atrial ...

Invasive epicardial coronary physiologic assessment is increasingly performed to evaluate the hemodynamic significance of ...

One month of dual antithrombotic therapy followed by direct oral anticoagulation alone may be as safe vs. 1 year of dual ...

Chinese researchers are developing quantum measurement technologies which can detect tiny changes in the body’s magnetic ...

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.

CARDIAMP CMI Cohort Results -- In the open-label rolling cohort (n=5), patients saw an average 80-second increase in exercise tolerance, 82% mean reduction in angina episodes at six months, and 60% ...

All experimental procedures were approved by the University of Toronto Animal Care and Use Committee and follow the rules set out by the Guide for the Care and Use of Laboratory Animals published by ...